Jpmorgan Chase & CO Novavax Inc Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Novavax Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 81,989 shares of NVAX stock, worth $706,745. This represents 0.0% of its overall portfolio holdings.

Number of Shares

81,989

Previous 76,576 7.07%

Holding current value

$706,745

Previous $615,000 14.63%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$6.41 - $10.82 $34,697 - $58,568	5,413 Added 7.07%	81,989 $525,000
Q4 2024 Feb 12, 2025	SELL	$7.22 - $14.68 $23,818 - $48,429	-3,299 Reduced 4.13%	76,576 $615,000
Q3 2024 Dec 26, 2024	SELL	$10.71 - $17.11 $43,268 - $69,124	-4,040 Reduced 4.81%	79,875 $1.01 Million
Q3 2024 Nov 08, 2024	SELL	$10.71 - $17.11 $43,268 - $69,124	-4,040 Reduced 4.81%	79,875 $1.01 Million
Q2 2024 Dec 26, 2024	BUY	$3.89 - $20.97 $15,715 - $84,718	4,040 Added 5.06%	83,915 $1.06 Million
Q2 2024 Aug 12, 2024	SELL	$3.89 - $20.97 $133,722 - $720,864	-34,376 Reduced 29.06%	83,915 $1.06 Million
Q1 2024 Dec 26, 2024	BUY	$3.76 - $6.02 $144,444 - $231,264	38,416 Added 48.1%	118,291 $565,000
Q1 2024 May 10, 2024	SELL	$3.76 - $6.02 $157,630 - $252,376	-41,923 Reduced 26.17%	118,291 $565,000
Q4 2023 Dec 26, 2024	BUY	$4.8 - $7.67 $385,627 - $616,200	80,339 Added 100.58%	160,214 $769,000
Q4 2023 Feb 12, 2024	BUY	$4.8 - $7.67 $123,297 - $197,019	25,687 Added 19.09%	160,214 $769,000
Q3 2023 Nov 14, 2023	SELL	$6.81 - $9.74 $21,328 - $30,505	-3,132 Reduced 2.28%	134,527 $973,000
Q2 2023 Aug 11, 2023	BUY	$6.67 - $9.52 $309,394 - $441,594	46,386 Added 50.82%	137,659 $1.02 Million
Q1 2023 May 18, 2023	BUY	$5.76 - $12.48 $276,779 - $599,688	48,052 Added 111.18%	91,273 $632,000
Q1 2023 May 11, 2023	SELL	$5.76 - $12.48 $11,813 - $25,596	-2,051 Reduced 4.53%	43,221 $299,000
Q4 2022 Feb 13, 2023	SELL	$8.86 - $25.04 $59,521 - $168,218	-6,718 Reduced 12.92%	45,272 $465,000
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $91,018 - $380,676	-5,001 Reduced 8.78%	51,990 $946,000
Q2 2022 Aug 11, 2022	SELL	$36.28 - $75.29 $484,156 - $1 Million	-13,345 Reduced 18.97%	56,991 $2.93 Million
Q1 2022 May 11, 2022	BUY	$69.73 - $142.9 $716,615 - $1.47 Million	10,277 Added 17.11%	70,336 $5.18 Million
Q4 2021 Feb 10, 2022	SELL	$134.56 - $217.97 $26.8 Million - $43.4 Million	-199,329 Reduced 76.85%	60,059 $8.59 Million
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $46.1 Million - $70.2 Million	259,388 New	259,388 $53.8 Million

Others Institutions Holding NVAX

# of Institutions

314

Shares Held

94.7M

Call Options Held

6.11M

Put Options Held

10.5M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $674M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Novavax Inc Transaction History